Cargando…
IgA Vasculitis Following COVID-19 Vaccination
As new variants of SARS-CoV-2 continue to emerge worldwide, countries are striving to fully vaccinate their population in a bid to prevent severe disease, subsequent hospitalizations, and the associated strain on their healthcare systems and death. In this context, there is growing evidence of rare,...
Autores principales: | Rista, Elvana, Strakosha, Arjana, Saliaj, Kristi, Ymeri, Florida, Ikonomi, Majlinda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937717/ https://www.ncbi.nlm.nih.gov/pubmed/36819313 http://dx.doi.org/10.7759/cureus.33938 |
Ejemplares similares
-
Reactivation of IgA vasculitis following COVID-19 vaccination
por: Maye, James A, et al.
Publicado: (2021) -
The Role of IgA in Chronic Upper Airway Disease: Friend or Foe?
por: Sánchez Montalvo, Alba, et al.
Publicado: (2022) -
Pathogenesis of IgA Vasculitis: An Up-To-Date Review
por: Song, Yan, et al.
Publicado: (2021) -
IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers
por: Xu, Liyun, et al.
Publicado: (2022) -
Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers
por: Alharbi, Suliman A, et al.
Publicado: (2020)